Prognostic Genetic Signatures in Upper Tract Urothelial Carcinoma Review uri icon

Overview

MeSH Major

  • Urinary Bladder Neoplasms

abstract

  • Urothelial carcinoma is a highly heterogeneous disease that can arise throughout the entire urothelial lining from the renal pelvis to the proximal urethra. Upper tract urothelial carcinoma (UTUC) is rare, and while it shares many similarities with urothelial carcinoma of bladder (UCB), there are also significant differences between UTUC and UCB regarding clinical management and outcomes. No major advances have been made recently in the development of new systemic therapies for urothelial carcinoma, partly due to the lack of understanding of underlying molecular pathogenetic mechanisms. In the past decade, the emergence of next-generation sequencing has greatly enabled genomic characterization of tumor samples. Researchers are currently exploring a personalized approach to augment traditional clinical decision-making based on genetic alterations. In the present review, we summarize current genomic advances in UTUC and discuss the potential implications of these developments for developing prognostic and predictive biomarkers.

publication date

  • February 2016

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC4823991

Digital Object Identifier (DOI)

  • 10.1007/s11934-015-0566-y

PubMed ID

  • 26757906

Additional Document Info

start page

  • 12

volume

  • 17

number

  • 2